Business Description
LTR Pharma Ltd
ISIN : AU0000305294
Description
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 1 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.14 | |||||
| 9-Day RSI | 29.95 | |||||
| 14-Day RSI | 34.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 343.33 | |||||
| Quick Ratio | 343.33 | |||||
| Cash Ratio | 340.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.88 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -31.44 | |||||
| ROA % | -29.83 | |||||
| ROIC % | -439.14 | |||||
| ROC (Joel Greenblatt) % | -3306.82 | |||||
| ROCE % | -31.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.63 | |||||
| Price-to-Tangible-Book | 5 | |||||
| EV-to-EBIT | -24.1 | |||||
| EV-to-EBITDA | -24.1 | |||||
| EV-to-FCF | -23.25 | |||||
| Price-to-Net-Current-Asset-Value | 5 | |||||
| Price-to-Net-Cash | 5 | |||||
| Earnings Yield (Greenblatt) % | -4.16 | |||||
| FCF Yield % | -4.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LTR Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.01 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 34.86 | ||
| 14-Day ATR (A$) | 0.012919 | ||
| 20-Day SMA (A$) | 0.27675 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (A$) | 0.235 - 0.41 | ||
| Shares Outstanding (Mil) | 139.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LTR Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LTR Pharma Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
LTR Pharma Ltd Frequently Asked Questions
What is LTR Pharma Ltd(ASX:LTP)'s stock price today?
The current price of ASX:LTP is A$0.25. The 52 week high of ASX:LTP is A$0.41 and 52 week low is A$0.24.
When is next earnings date of LTR Pharma Ltd(ASX:LTP)?
The next earnings date of LTR Pharma Ltd(ASX:LTP) is .
Does LTR Pharma Ltd(ASX:LTP) pay dividends? If so, how much?
LTR Pharma Ltd(ASX:LTP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers